Hemagglutinin-Specific Non-neutralizing Antibody Is Essential for Protection Provided by Inactivated and Viral-Vectored H7N9 Avian Influenza Vaccines in Chickens

Novel correlates of protection against pandemic H1N1 influenza A virus infection

(2019) Sophia Ng et al.   NATURE MEDICINE

Characteristics of the emerging chicken-origin highly pathogenic H7N9 viruses: A new threat to public health and poultry industry

(2018) Dong Liu et al.   JOURNAL OF INFECTION

Rapid Evolution of H7N9 Highly Pathogenic Viruses that Emerged in China in 2017

(2018) Jianzhong Shi et al.   Cell Host & Microbe

Tackling a novel lethal virus: a focus on H7N9 vaccine development

(2017) Irina Isakova-Sivak et al.   Expert Review of Vaccines

Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China

(2017) Fuchun Zhang et al.   JOURNAL OF INFECTION

Human infection caused by an avian influenza A (H7N9) virus with a polybasic cleavage site in Taiwan, 2017

(2017) Ji-Rong Yang et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies

(2017) Ram P. Kamal et al.   JOURNAL OF VIROLOGY

Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013–17: an epidemiological study of laboratory-confirmed case series

(2017) Xiling Wang et al.   LANCET INFECTIOUS DISEASES

Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges

(2017) Zenglei Hu et al.   VACCINE

Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design

(2017) Zenglei Hu et al.   Frontiers in Microbiology

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans

(2017) Daniel Stadlbauer et al.   mSphere

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

(2016) Carole J. Henry Dunand et al.   Cell Host & Microbe

Reassortant H5N1 avian influenza viruses containing PA or NP gene from an H9N2 virus significantly increase the pathogenicity in mice

(2016) Xiaoli Hao et al.   VETERINARY MICROBIOLOGY

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

(2016) Gene S. Tan et al.   PLoS Pathogens

Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses

(2015) Qinfang Liu et al.   JOURNAL OF VIROLOGY

Enzootic genotype S of H9N2 avian influenza viruses donates internal genes to emerging zoonotic influenza viruses in China

(2014) Min Gu et al.   VETERINARY MICROBIOLOGY

The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines

(2013) Florian Krammer et al.   Expert Review of Vaccines

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus

(2013) Rongbao Gao et al.   NEW ENGLAND JOURNAL OF MEDICINE

High Titer and Avidity of Nonneutralizing Antibodies against Influenza Vaccine Antigen Are Associated with Severe Influenza

(2012) Kelvin K. W. To et al.   Clinical and Vaccine Immunology

Generation of a Genotype VII Newcastle Disease Virus Vaccine Candidate with High Yield in Embryonated Chicken Eggs

(2011) Zenglei Hu et al.   AVIAN DISEASES

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

(2011) Steven Black et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL